Progressive Care, Inc.

Global Telesat Begins Sales of SpaceX's Starlink as Authorized Reseller Through Joint Venture Agreement with Pivotel Solutions Inc. (dba Pulsar) Joint Venture Expands Global Telesat's Portfolio of Satellite-Based Connectivity Solutions with Starlink's Low Earth Orbit (LEO) Network COCONUT…...

$NXPL NextPlat Reports Record Consolidated Q1 2024 Revenues of $17.5 Million Compared to $2.9 Million in Q1 2023 (508% Increase) as Quarterly Margins Improve to 27.5% - https://bit.ly/3wDwfyq

NextPlat Reports Record Consolidated Q1 2024 Revenues of $17.5 Million Compared to $2.9 Million in Q1 2023 (508% Increase) as Quarterly Margins Improve to 27.5% Proposed Merger Agreement with Progressive Care Inc., Launch of its E-Commerce Development Program with Alibaba's Tmall Global and Acquisition…...

$NXPL NextPlat Announces Proposed Business Combination with Progressive Care, Inc.: Transaction Expected to Provide Revenue Synergies and Significant Initial Annual Operating Cost Reductions - https://bit.ly/3JhRvwm $RXMD

NextPlat Announces Proposed Business Combination with Progressive Care Inc. Transaction Expected to Provide Revenue Synergies and Significant Initial Annual Operating Cost Reductions COCONUT GROVE, Fla. and MIAMI, April…...

NextPlat Reports Consolidated Year-End 2023 Results with Increased Revenues of $37.8 Million, Record Annual Margins of 30% and $26.3 Million in Cash; Company Expands Healthcare and Technology Focus Through the Launch of its E-Commerce Development Program with Alibaba Group's Tmall Global and Strategic Investment in Progressive Care, Inc. -https://bit.ly/4aOsrsp $RXMD

$RXMD Progressive Care Announces Record 2023 Results- Revenues of $49.7 Million, an Increase of 22% with Annual Gross Margins of 30%; Results Driven by 17% Increase in Pharmacy Prescription Revenue & Over 136% Growth in 340B Contract Services Revenue -

Progressive Care Inc. Announces Record Full Year 2023 Results with Revenues of $49.7 Million, an Increase of 22% with Annual Gross Margins of 30% | Progressive Care Inc. Results Driven by 17% Increase in Pharmacy Prescription Revenue and Over 136% Growth in 340B Contract Services Revenue

NextPlat Expands North American Technology E-Commerce Business with Acquisition of Outfitter Satellite Inc. Accretive Acquisition to More Than Double North American Technology E-Commerce Product Sales and Recurring Revenue through Consumer, Commercial…...

$NXPL NextPlat Opens OPKO Health, Inc.-Branded Storefront on Alibaba Group's Tmall Global Platform in China on March 1st: New Health & Wellness Storefront Launches After Receiving All Required Approvals - https://bit.ly/3wwz1oF

NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st New Health and Wellness E-Commerce Storefront Launches After Receiving All Required Approvals with Initial Selection of OPKO Health…...

$NXPL NextPlat Receives Initial Approvals to Launch OPKO Health, Inc.-Branded Storefront Alibaba Group's Tmall Global Platform in China: E-Commerce Storefront to Initially Support Sales of up to 40 Personal Health & Wellness Products; Final International Certifications & Approvals Required for Formal Launch Expected This Quarter - https://bit.ly/3uwaTlk

NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China E-Commerce Storefront to Initially Support Sales of up to 40 Personal Health and Wellness Products; Final International Certifications and…...

$RXMD $NXPL Progressive Care's PharmcoRx Pharmacy Expands
Medicare Advantage Over-the-Counter Benefits Acceptance Program Through New Agreement with ProHealth Connect - https://bit.ly/3TpoVPT

Progressive Care’s PharmcoRx Pharmacies Expands Medicare Advantage Over-the-Counter Benefits AcceptanceProgram Through New Agreement with ProHealth Connect | Progressive Care Inc. Program Expands PharmcoRx’s Ability to Provide Patient Access to Supplemental Health Insurance Benefits for the In-Pharmacy Purchase of Over-the-Counter Products

$RXMD $NXPL Progressive Care Inc's PharmcoRx Pharmacy Launches Mark Cuban Cost Plus Drug Company Program Expanding Its In-Pharmacy Offerings - https://bit.ly/49NXvsV

PharmcoRx Pharmacy Launches Mark Cuban Cost Plus Drug Program Expanding Its In-Pharmacy Offerings | Progressive Care Inc. Miami, FL – November 27 – PharmcoRx Pharmacy, a wholly-owned subsidiary of Progressive Care Inc (OTCQB: RXMD), today announced its expansion of in-pharmacy offerings through an agreement with the Mark Cuban Cost Plus Drug Company (“Cost PlusDrugs”). The Cost Plus Drugs program allows partici...

$RXMD $NXPL Progressive Care, Inc.'s PharmcoRx Enters into Agreement with NationsBenefits to Offer Enhanced OTC Benefits; OTC Program Expands PharmcoRx Pharmacy’s Ability to Provide Patients with Access to Additional Healthcare Benefits Covered by Medicare Advantage Plans - https://bit.ly/47FraT1

Progressive Care’s PharmcoRx Enters into Agreement with NationsBenefits to Offer Enhanced OTC Benefits to Health Plan Members | Progressive Care Inc. Latest OTC Program Expands PharmcoRx Pharmacy’s Ability to Provide Patients with Access to Additional Healthcare Benefits Covered by Medicare Advantage Plans

NextPlat Reports Consolidated Third Quarter 2023 Results with Increased Revenues of $15.3 Million, Margins Improve to 30% and $2.7 Million Net Income Company Sees Double-Digit Growth at Both its Healthcare and e-Commerce Operations; Balance Sheet Features $26.3 Million in Cash to Help…...

$RXMD Progressive Care Inc. Announces Record Third Quarter 2023 Revenues of $12.4Million, an Increase of 22%, as Gross Margins Improve to 31% Over Third Quarter 2022 Results - https://bit.ly/3G0eBG0

Progressive Care Inc. Announces Record Third Quarter 2023 Revenues of $12.4 Million, an Increase of 22%, as Gross Margins Improve to 31% Over Third Quarter 2022 Results | Progressive Care Inc. Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology provider, today announced financial results for its third quarter ended September 30, 2023. The Company reported record third-quarter revenues of $12.4 million, a 22% ...

NextPlat to Present at 8th Annual Dawson James Conference COCONUT GROVE, FL, Oct. 04, 2023 (GLOBE NEWSWIRE) -- NextPlat Corp (NASDAQ: NXPL, NXPLW) (“NextPlat” or the “Company”), a global…...

The Company is delighted to welcome our current Chairman of the Board, Charles M. Fernandez as the Company’s new Chief Executive Officer. On November 11, 2022, Alan Jay Weisberg, Chief Executive Officer, and Vice-Chairman of the Board, resigned effective immediately. On the same date, the Board appointed Charles to serve as the new CEO effective immediately.

“Yesterday we announced that Jay Weisberg, our former CEO, had resigned his positions as CEO and Vice-Chair of the Board of Directors. Progressive Care is greatly indebted to Jay’s leadership and guidance to the Company as we emerged from the pandemic. Jay will remain available to us on a consulting basis as we continue our transition to a diversified technology-driven healthcare company. Upon Jay’s resignation, the Directors of Progressive Care appointed me as the Chief Executive Officer. As many of you are aware, I had joined the Board of Directors of Progressive Care as the Chairman in September. My appointment as Chairman was part of the $6 million investment made in Progressive Care in September 2022 by NextPlat Corporation, the Company of which I am also the CEO and Executive Chairman. I will receive no salary or other forms of compensation for my work as CEO of Progressive Care. I am taking on this role with the goal of maximizing the synergies that exist between NextPlat and Progressive Care. “ said Charles M. Fernandez, CEO of Progressive Care.

To all those who have served, and those who continue to serve… Happy Veterans Day!

Progressive Care has scheduled an investor conference call at 4:30 PM ET on Monday, November 14th, 2022.

Co-vice chairman and CEO, Alan Jay Weisberg, stated, “It has been an exciting quarter for the company and we are really looking forward to sharing developments with our shareholders.”

Those attending the investor conference call will have the opportunity to submit questions concerning the Company to Stuart Smith of SmallCapVoice.Com, Inc. via e-mail: [email protected] by 12:00 PM EST on Friday, November 11th, 2022. The Company plans to address as many appropriate questions as possible.

To access the call:
Dial-In Number: 1-857-232-0157

Access Code: 422095

For those unable to participate in the live conference call, a replay will be available at

https://www.smallcapvoice.com/clients/rxmd/

Shortly after the call has concluded.
An archived version of the webcast will also be available

https://progressivecareus.com/news-releases/

Happy Labor Day to the workers of every field! The world runs on your contributions and you all deserve respect, recognition, and a day to relax. We hope you have a great one!

Under the agreement, Progressive Care will receive an aggregate of $6 million from NextPlat in exchange for the issuance to NextPlat of 3,000 units of Series B Preferred Stock as well as warrants to purchase up to 3,000 shares of Series B Preferred Stock at an exercise price of $2,000 per share. In addition, NextPlat’s Executive Chairman and CEO, Charles M. Fernandez, board member, Rodney Barreto, and certain other investors will purchase approximately $2.8 million of outstanding convertible debt in Progressive Care at an agreed fixed conversion price of $0.02 per share. Progressive Care and NextPlat agreed to reduce the interest rate on the purchased debt from 10% to 5% per annum and extend the maturity date to August 30, 2027.

Click on our website to learn what our partners have said about us

Click on our website to read more about us

We are a healthcare technology organization and provider of prescription pharmaceuticals, compounded and anti-retroviral medications, the supplier of prescription medications to long-term care facilities, provider of medication therapy management (MTM), remote therapy management, COVID-19 testing and immunizations, tele-pharmacy services, third-party administration management and reporting and health practice risk management

We take pride in being more than your average pharmacy. We are committed to providing effective, timely, and affordable medications to our patients and the surrounding communities, but our devotion to this mission goes above and beyond.

ClearMetrX is a full-stack reporting platform that simplifies data analytics for physicians, MSO organizations, 340B entities, and pharmacies.

Click on our website to learn more about our data management industry overview

Progressive Care is disrupting the managed healthcare industry
With solutions to enhance prescriber's performance and patient satisfaction

More fast facts about the 340B Program

Some important facts about the

Disproportionate share hospitals (DSH) are eligible to participate in 340B if their DSH adjustment–a measure that identifies hospitals that treat a disproportionate share of low-income Medicare or Medicaid patients–is above 11.75%